Article Versions Notes

Onishi R, Sawaya R, Tsuji K, Arihara N, Ohki A, Ueda J, Hata J, Saito S. Evaluation of Temozolomide Treatment for Glioblastoma Using Amide Proton Transfer Imaging and Diffusion MRI. Cancers. 2022; 14(8):1907. https://doi.org/10.3390/cancers14081907

Onishi, Ryutarou, Reika Sawaya, Keiho Tsuji, Narumi Arihara, Akiko Ohki, Junpei Ueda, Junichi Hata, and Shigeyoshi Saito. 2022. "Evaluation of Temozolomide Treatment for Glioblastoma Using Amide Proton Transfer Imaging and Diffusion MRI" Cancers 14, no. 8: 1907. https://doi.org/10.3390/cancers14081907

Onishi, R., Sawaya, R., Tsuji, K., Arihara, N., Ohki, A., Ueda, J., Hata, J., & Saito, S. (2022). Evaluation of Temozolomide Treatment for Glioblastoma Using Amide Proton Transfer Imaging and Diffusion MRI. Cancers, 14(8), 1907. https://doi.org/10.3390/cancers14081907